Ownership. CDS is the sole record holder and beneficial owner of the Class B Membership Interest. CDS owns the Class B Membership Interest free and clear of all Liens. There are no outstanding rights, options, warrants, conversion rights, repurchase rights, agreements, arrangements, calls, commitments or rights of any kind that obligate CDS to sell the Class B Membership Interest or any securities or obligations convertible or exchangeable into or exercisable for, or giving any person a right to subscribe for or acquire the Class B Membership Interest.

Ownership. [[FR54:Organization]] is the sole record holder and beneficial owner of the [[FR54:Organization]] Series C Shares. [[FR54:Organization]] owns the [[FR54:Organization]] Series C Shares free and clear of all Liens. There are no outstanding rights, options, warrants, conversion rights, repurchase rights, agreements, arrangements, calls, commitments or rights of any kind that obligate [[FR54:Organization]] to sell the [[FR54:Organization]] Series C Shares or any securities or obligations convertible or exchangeable into or exercisable for, or giving any person a right to subscribe for or acquire the [[FR54:Organization]] Series C Shares.

Ownership. All determinations of inventorship under this Agreement will be made in accordance with the laws of the United States.

Ownership. [[Forty Seven:Organization]] shall own the entire right, title and interest in and to all inventions first made, conceived or reduced to practice solely by or on behalf of [[Forty Seven:Organization]] or its Affiliates. Ono shall own the entire right, title and interest in and to all inventions first made, conceived or reduced to practice solely by or on behalf of Ono or its Affiliates. The Parties shall jointly own the entire right, title and interest in and to all inventions first made, conceived or reduced to practice jointly by employees of [[Forty Seven:Organization]] or its Affiliates and employees of Ono or its Affiliates.

Ownership. It, itself or together with one or more of its Affiliates, solely owns the [[AbbVie:Organization]] Know-How and the [[AbbVie:Organization]] Patents and is entitled to grant the licenses and make the assignments specified herein.

Ownership. NOF agrees that, as between the Parties, Apellis owns all right, title, and interest in and to the Drug Substance and the Drug Product, as applicable, and all Apellis IP (collectively “Apellis Property”), and to the extent NOF or any of its Affiliates has or may acquire or be deemed to have acquired any rights in Apellis Property, NOF hereby agrees, on behalf of itself and its Affiliates, to transfer and assign, and hereby transfers and assigns, its and its Affiliates’ right, title, and interest in such property to Apellis. Upon Apellis’s request at any time, NOF shall, and shall require its Affiliates to, deliver to Apellis any and all documents and information necessary to protect Apellis’s interest in the Apellis Property to the extent that such documents and information are not confidential information of a Third Party. NOF shall promptly notify Apellis in writing of any Apellis Property that arises from the Manufacturing services.

Ownership. [[Intel:Organization]] acknowledges and agrees that [[Peraso:Organization]] owns and shall retain all Intellectual Property Rights in and to the Licensed Technology (excluding, for purposes of clarity, the Assigned Patents, which upon the Closing, are and shall at all times remain the sole and exclusive property of [[Intel:Organization]]) and that, except as expressly set forth herein, [[Intel:Organization]] shall have no right or license in or to the Licensed Technology (excluding, for purposes of clarity, the Assigned Patents, which upon the Closing, are and shall at all times remain the sole and exclusive property of [[Intel:Organization]]), whether by implication, estoppel or otherwise. [[Intel:Organization]] shall not make use of the Licensed Technology (excluding, for purposes of clarity, the Assigned Patents, which upon the Closing, are and shall at all times remain the sole and exclusive property of [[Intel:Organization]]) except as expressly authorized in this Agreement.

Ownership. The Borrowers own and have good and marketable title to the Lock-Box Accounts free and clear of any Adverse Claim.

Ownership. Any “Person” (as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended) becomes the “Beneficial Owner” (as defined in Rule 13d-3 under said Act), directly or indirectly, of securities of Stoke representing fifty percent (50%) or more of the total voting power represented by Stoke’s then outstanding voting securities (excluding for this purpose any such voting securities held by Stoke, or any affiliate, parent or subsidiary of Stoke, or by any employee benefit plan of Stoke) pursuant to a transaction or a series of related transactions which Stoke’s Board of Directors (the “Board”) does not approve; or

Ownership. For avoidance of doubt, as between the Parties and subject to the Acer Technology License and the Acer Sublicense, Acer is the sole owner of all rights, title and interest in and to all Acer Patents, Acer Know-How and Development Data, and all intellectual property rights (including patent, copyright, trade secret and application of patent) therein, including any and all existing or future rights, whether patentable or not. Relief agrees and hereby irrevocably transfers and assigns to Acer any and all such rights, title and interest, and will perform and, if necessary, obligate its personnel to perform any and all other reasonable acts necessary to assist Acer in obtaining, maintaining, implementing, securing and perfecting any and all such rights, title and interest, including executing the necessary documents by Relief or its personnel.